FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

UK UK

Industries

  • Medicine ‎1
    • Medical Supplies ‎1

Contact Info

Location

Oxford Nanopore Technologies Ltd

  • 1Product
  • 1Types
  • 1Industry

About Company

Oxford Nanopore Technologies Ltd is a private company headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India. The company sells to nearly 100 countries and is in a period of rapid growth. Oxford Nanopore was founded in 2005 to develop a disruptive, electronic,

Oxford Nanopore Technologies Ltd is a private company headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India. The company sells to nearly 100 countries and is in a period of rapid growth. Oxford Nanopore was founded in 2005 to develop a disruptive, electronic, single-molecule sensing system based on nanopore science. The first product, MinION, was introduced into early access in 2014 and made commercially available in 2015. The scaled-up GridION was commercially launched in 2017 and PromethION in 2018, with the largest device, the PromethION 48, first shipped in 2019. Flongle, the adapter for MinION/GridION for rapid, cheaper, smaller tests was launched in 2019. The Company has a rich development pipeline that includes solutions to enable any user, anywhere, including the mobile-phone-compatible SmidgION and low cost, portable sample prep Ubik. The rich history of research and development that has resulted in nanopore sequencing is outlined below. The Company now has more than 1,400 patents and patent applications across 200 patent families, with hundreds generated by internal R&D, and complemented with key in-licenced IP from collaborators. Oxford Nanopore employs about 500 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.

Products

MinION sequencer

MEDICINE - MEDICAL SUPPLIES   |  GENOME SEQUENCER

MinION sequencer

Properties :

Portable,Real-time device

Application :

Coronavirus,COVID-19,DNA/RNA sequencing

Analytical Reports